Home » MANHATTAN PHARMACEUTICALS TO MERGE WITH TARPAN THERAPEUTICS
MANHATTAN PHARMACEUTICALS TO MERGE WITH TARPAN THERAPEUTICS
Manhattan Pharmaceuticals has signed a letter of intent to merge with Tarpan Therapeutics, a privately held, New York-based pharmaceutical company developing dermatological therapeutics, in an all stock transaction. Upon consummation of the transaction, Tarpan shareholders will own approximately 20 percent of the shares of Manhattan on a fully-diluted basis.
Yahoo News (http://biz.yahoo.com/bw/050105/55430_1.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23May
-
30May
-
13Jun
-
20Jun
-
21Oct